Hospital And Nursing Home Probiotics Market Report 2026

Hospital And Nursing Home Probiotics Market Overview

• Hospital And Nursing Home Probiotics market size has reached to $1.69 billion in 2025 • Expected to grow to $2.86 billion in 2030 at a compound annual growth rate (CAGR) of 11.1% • Growth Driver: Impact Of Rising Gastrointestinal Disorders On The Growth Of The Market • Market Trend: Innovation in Probiotics for Hospital and Nursing Home Settings • North America was the largest region in 2025.

What Is Covered Under Hospital And Nursing Home Probiotics Market?

Hospital and nursing home probiotics are dietary supplements containing live microorganisms that offer health benefits. They support digestive health, enhance immune function, and improve overall wellbeing. These probiotics are especially beneficial for vulnerable populations, including elderly patients and those with weakened immune systems. The main types of indications for hospital and nursing home probiotics are antibiotic-associated diarrhea, irritable bowel syndrome, clostridium difficile infection, inflammatory bowel disease, and general gut health. Antibiotic-associated diarrhea is diarrhea caused by antibiotic use, disrupting gut microbiota and leading to gastrointestinal disturbances, often managed with probiotics in healthcare settings. It is available in different formulation types, such as capsules, powder, liquid, soft chew, and probiotic yogurt. It is used across various patient groups, such as infants, adults, the elderly, immunocompromised patients, and patients with gastrointestinal disorders. It is distributed through various channels such as hospitals, nursing homes, pharmacies, online retail, and healthcare facilities, and it is primarily applied in areas such as gut health, immunity, wellness, and others.

What Is The Hospital And Nursing Home Probiotics Market Growth Forecast?

The hospital and nursing home probiotics market size is expected to see rapid growth in the next few years. It will grow to $2.86 billion in 2030 at a compound annual growth rate (CAGR) of 11.1%. The growth in the forecast period can be attributed to rising focus on microbiome-based health management, increasing demand for immune support solutions, growing incidence of gastrointestinal disorders, expansion of hospital-based preventive care programs, increasing use of probiotics in long-term care facilities. Major trends in the forecast period include increasing use of probiotics in clinical nutrition protocols, growing adoption of probiotics for elderly and immunocompromised care, rising integration of probiotics in preventive healthcare regimens, expansion of condition-specific probiotic formulations, increasing acceptance of probiotics as adjunct therapy in hospitals.

What Is The Driver Of The Hospital And Nursing Home Probiotics Market?

The increasing prevalence of gastrointestinal disorders is expected to propel the growth of the hospital and nursing home probiotics market going forward. Gastrointestinal disorders refer to a range of conditions affecting the digestive tract, including irritable bowel syndrome (IBS), inflammatory bowel disease (IBD), gastroesophageal reflux disease (GERD), and constipation. The rising incidence of gastrointestinal disorders is attributed to factors such as poor dietary habits, increased consumption of processed foods, sedentary lifestyles, and higher stress levels. Hospital and nursing home probiotics help manage gastrointestinal disorders by restoring the balance of beneficial gut bacteria, promoting digestive health, and alleviating symptoms such as diarrhea, constipation, and bloating. For instance, in December 2023, according to the IBD Registry, a UK-based non-profit organization, by 2023, the number of individuals with Inflammatory Bowel Disease (IBD) reached over 5,300, marking an increase of more than 3,000 members compared to 2022. Therefore, the increasing prevalence of gastrointestinal disorders is driving the growth of the hospital and nursing home probiotics industry.

Key Players In The Global Hospital And Nursing Home Probiotics Market

Major companies operating in the hospital and nursing home probiotics market are Nestlé Health Science, Abbott Laboratories, Danone S.A., Yakult Honsha Co. Ltd., BioGaia AB, Lactalis Group, General Mills Inc., Arla Foods Group, Glanbia PLC, SymbioPharm GmbH, Klaire Labs, Procter & Gamble Company, Vitakem Nutraceuticals, Synlogic Inc., Bayer AG, Sanofi, Meiji Holdings Co. Ltd., Morinaga Milk Industry Co. Ltd., Otsuka Holdings Co. Ltd., Reckitt Benckiser Group plc

Global Hospital And Nursing Home Probiotics Market Trends and Insights

Major companies operating in the hospital and nursing home probiotics market are focusing on developing innovative products such as probiotic solutions to enhance patient gut health, improve recovery times, and reduce antibiotic-associated side effects. Probiotic solutions refer to products containing live microorganisms that provide health benefits when consumed in adequate amounts, typically by improving the balance of beneficial bacteria in the digestive system. For instance, in October 2024, Probi AB, a Sweden-based biotechnology company specializing in probiotics, launched Metabolic Health by Probi for healthcare settings. metabolic health by probi is a clinically backed probiotic solution designed to support metabolic well-being, cardiovascular health, weight management, and blood pressure regulation by combining two proprietary probiotic strains, Lactiplantibacillus plantarum 299v (LP299V) and Lacticaseibacillus paracasei 8700:2 (L. Paracasei 8700:2).

What Are Latest Mergers And Acquisitions In The Hospital And Nursing Home Probiotics Market?

In June 2023, Clasado Limited, a UK-based biotechnology company, partnered with Probi AB to advance synbiotic product development targeting gut health. The aim of the partnership between Clasado Limited and Probi AB is to leverage their combined expertise to advance the development and commercialization of scientifically backed synbiotic products that target specific consumer health benefits. Probi AB is a Sweden-based biotechnology company that specializes in developing and commercializing probiotic-based products supported by scientific research, preclinical, and clinical trials.

What Defines the Hospital And Nursing Home Probiotics Market?

The hospital and nursing home probiotics market includes revenues earned by entities by sales of probiotic-infused wound care products, probiotic-infused foods, and medical-grade probiotics and related services such as probiotic therapy and consultation, infection control and prevention, probiotic supplementation programs, and probiotic administration monitoring. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Hospital And Nursing Home Probiotics Market Report 2026?

The hospital and nursing home probiotics market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the hospital and nursing home probiotics industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.